Safety of JAK Inhibitors
0:47: What do rheumatologists need to know about the recent press release from Pfizer regarding the safety of JAK inhibitors?
2:47: According to analysts, the response to the safety of JAK inhibitors is not surprising. Did you expect this scrutiny in JAK inhibitors?
7:12: What are some of the concerns rheumatologist have in regards to the safety of JAK inhibitors?
9:22: What are your thoughts on prescribing JAK inhibiting drugs to your patients?
11:21: What does this mean for the future of JAK inhibitors?
11:52: Is there anything else you'd like our audience to know before you wrap up?